Hydrea (Novartis)

What is it?

A DNA reactive cytotoxic drug available as pink/green capsules containing 500mg hydroxyurea marked SQUIBB and 830.

Medical Uses

Treatment of chronic myeloid leukaemia.

Dosage

20-30mg/kg body weight each day or 80mg/kg body weight every third day.

Known Side Effects

Nausea, vomiting, skin rashes, bone marrow suppression.

Manufacturer

Novartis.